Wird geladen...
Which MCI patients should be included in prodromal Alzheimer’s disease clinical trials?
BACKGROUND: Prodromal Alzheimer’s disease (AD) clinical trials enroll patients with Mild Cognitive Impairment (MCI) meeting biomarker criteria, but specific enrollment criteria vary among trials. METHODS: We used data from AD Neuroimaging Initiative (ADNI) MCI participants to assess AD biomarker eli...
Gespeichert in:
| Veröffentlicht in: | Alzheimer Dis Assoc Disord |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6538436/ https://ncbi.nlm.nih.gov/pubmed/30958413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000303 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|